Evidence map›Paper›PMID 32413527›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2020

COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, Alessio Bruni, Michela Buglione di Monale E Bastia, Gianpiero Catalano, Andrea Riccardo Filippi, Pierfrancesco Franco, Maria Antonietta Gambacorta, Domenico Genovesi and 16 more

Abstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Preoperative accelerated hypofractionated radiotherapy (PHYPORT): state of art and potential clinical application.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. An Innovative Technique of Microsurgical Training on Fresh "Chicken Quarter" Model: Our Experience.Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Barbara Alicja Jereczek-FossaDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy.
Matteo PepaDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Giulia MarvasoDivision of Radiation Oncology, IEO, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy. Electronic address: giulia.marvaso@ieo.it.
Alessio BruniRadiotherapy Unit, Department of Oncology and Haematology, University Hospital of Modena, Modena, Italy.
Michela Buglione di Monale E BastiaDepartment of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
Gianpiero CatalanoRadiation Oncology Center, IRCCS Ospedale Multimedica, Sesto San Giovanni/Castellanza, Italy.
Andrea Riccardo FilippiDepartment of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
Pierfrancesco FrancoDepartment of Oncology, University of Turin, Torino, Italy.
Maria Antonietta GambacortaDepartment of Radiation Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.
Domenico GenovesiRadiation Oncology Unit, "SS Annunziata" Hospital, "G. D'Annunzio" University, Chieti, Italy.
Giuseppe IatìRadiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.
Alessandro MagliDepartment of Radiation Oncology, Udine General Hospital, Udine, Italy.
Luigi MarafiotiDivision of Radiotherapy, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
Icro MeattiniRadiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy; Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence, Firenze, Italy.
Anna MerlottiDepartment of Radiation Oncology, S. Croce and Carle Teaching Hospital, Cuneo, Italy.
Marcello MignognaRadiation Oncology Unit, S. Luca Hospital, Healthcare Company Tuscany Nord Ovest, Lucca, Italy.
Daniela MusioDepartment of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Roma, Italy.
Roberto PacelliDepartment of Advanced Biomedical Sciences, Federico II University, Napoli, Italy.
Stefano PergolizziRadiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.
Vincenzo TomboliniDepartment of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Roma, Italy.
Marco TrovòDepartment of Radiation Oncology, Udine General Hospital, Udine, Italy.
Umberto RicardiDepartment of Oncology, University of Turin, Torino, Italy.
Stefano Maria MagriniDepartment of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
Renzo CorvòDepartment of Radiation Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Health Science Department (DISSAL), University of Genoa, Genova, Italy.
Vittorio DonatoRadiation Oncology Division, Oncology and Speciality Medicine Department, San Camillo-Forlanini Hospital, Roma, Italy; President of AIRO (Italian Association of Radiotherapy and Clinical Oncology), Italy.
AIRO (Italian Association of Radiotherapy and Clinical Oncology)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.

Indexed as

BetacoronavirusCoronavirus InfectionsMedical OncologyPandemicsPneumonia, ViralCOVID-19Disease OutbreaksHumansItalyNeoplasmsSARS-CoV-2Surveys and QuestionnairesAIRO (Italian Association of Radiotherapy and Clinical Oncology)COVID-19ItalyRadiation oncologySurvey

Identifiers

PMID32413527
PMCPMC7215158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.